First Treatment Campaign in Mali (January – April 2005)
The treatment campaign
against schistosomiasis and soil-transmitted helminths has now started in
Mali, and the target is to treat more than 2 million children and adults by
mid 2005.
The
National
Schistosomiasis Control Programme (PNLSG) was launched in November 2004 by
Mme Touré Lobbo Traoré, the First Lady of Mali in the region of Ségou, the
Fourth Administrative Region of Mali. Ségou has long been known to
specialists as one of the worst affected areas of West Africa, due to the
presence of the Office du Niger, a huge irrigation scheme draining
water from Niger River.
The treatment strategy
All the villages
situated along the Niger River, near to ponds, or in an irrigated zone were
targeted. Within each selected village, all children aged 5 to 15
(inclusive) were offered treatment. In addition all workers professionally
exposed to risk of transmission (fishermen, peasants working in irrigated
areas) were also offered treatment. The drugs Praziquantel (against
schistosomiasis) and Albendazole (against soil-transmitted helminths), were
provided free of charge using trained school teachers for treating
school-enrolled children, and fixed and mobile drug distribution teams for
the rest of the targeted populations. The campaign was supervised and
monitored by mobile teams who visited several schools and villages and
interviewed distribution teams and drug recipients during the event.
 
Results
The treatment campaign
in Ségou was divided in two parts. One Cercle (equivalent to a
District) was targeted in a pilot campaign from 15 to 20 February 2005; the
other six Cercles of the Region were targeted from 8 to 13 March.
In all 690,045 children
and adults have been treated in Ségou region. The overall coverage rate was
92%, but this is likely to increase as some areas could not be reached
during the campaign, and will be targeted a few weeks later, in the
framework of National Vaccination Days. In these remote villages, children
will be vaccinated against polio, and also receive praziquantel and
albendazole.
Acknowledgements
4 million tablets of Praziquantel were
donated by the pharmaceutical company MedPharm (http://www.medpharm.net/)
through World Health Initiatives. All institutions included in this
organisation and responsible for the donation are gratefully acknowledged:
- Escarpment Biosphere Foundation
- Canadian Physicians for Aid and Relief
- Universal Aide Society
- Meoroth of CanadaCK Fund of Toronto, Canada
- The Alberta Distribution Relief Agency
- Adventist Society International
- The Living Waters Ministry
- Phoenix Community Works Foundation
|